APRIL - 202519India's pharmaceutical manufacturing industry is growing rapidly driven by aspects such as developing domestic demand, export opportunity, and government support. This sector occupies a position of great importance in the world's healthcare system, and it is the world's topmost generic medicine supplier. Diversification is expected in the growing awareness among patients of the significance of health issues, incidence of lifestyle ailments, and income in the middle classes. The Indian pharmaceutical industry will likely reach $130 billion in 2030 at a growth rate of approximately 10-12 percent per annum. This is due to such initiatives taken by the government like the recently proclaimed Production Linked Incentive (PLI) scheme which have encouraged large-scale production while curtailing the dependence on current foreign sources for active pharmaceutical ingredients (APIs). This includes benefits derived from mergers, acquisitions, and joint ventures with MNCs. India has more than 3000 registered pharmaceutical industries and 10500 plus pharmaceutical manufacturing units which normally create a strong base for growth. Market changes are accompanied by supporting research and development investment focusing on innovative drug development, biosimilars, and speciality medicines. Technology is a big factor in revolutionizing drug manufacturing in the future. With the development of AI, machine learning, and automation, the work of drug discovery, drug quality testing, and drug manufacturing is becoming more efficient and productive. Various advanced manufacturing technologies like continuous manufacturing and 3D printing will also make a difference in streamlining pharmaceutical production processes. Greater transparency through the supply chain to reduce counterfeit medicines is provided by blockchain technology. With a strong regulatory framework and advances in technology, India continues to be the preferred destination for world-class affordable medicines. The future of Indian pharmaceutical manufacturing seems to be bright with future innovations and advancements in digital transformations.India Manufacturing Review in this issue presents a list of 'Top 10 Pharma Manufacturers in India - 2025' who have leveraged their extensive industry expertise and experience in offering high quality products in the industry. The following list has been prepared after being closely scrutinized by a distinguished panel of judges including CXOs, analysts, and our editorial board. We recognize their valuable contribution to the ever expanding and competitive market and their ability to sustain themselves and emerge as top contestants through their reliable products.PHARMA MANUFACTURERSIN INDIA - 2025INDIAREVIEWTOP 10
< Page 9 | Page 11 >